SEC Form 4 · accession 0001209191-18-004928
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Sachdev
Officer — EVP, CRO
Period of report
Jan 19, 2018
Accepted (ET)
Jan 23, 2018 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 19, 2018 | M | 18,672 | $77.31 | A | 57,835 | D | |
| Common Stock | Jan 19, 2018 | M | 13,750 | $83.36 | A | 71,585 | D | |
| Common StockF2,F3 | Jan 19, 2018 | S | 18,410 | $157.67 | D | 53,175 | D | |
| Common StockF3,F4 | Jan 19, 2018 | S | 13,312 | $158.59 | D | 39,863 | D | |
| Common StockF3,F5 | Jan 19, 2018 | S | 700 | $159.35 | D | 39,163 | D | |
| Common Stock | Jan 22, 2018 | M | 13,750 | $83.36 | A | 52,913 | D | |
| Common StockF6 | Jan 22, 2018 | S | 13,750 | $160.00 | D | 39,163 | D | |
| Common Stock | holding | — | — | — | 882 | I | 401(k) | |
| Common StockF6 | holding | — | — | — | 12,215 | I | Held in trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F7 | $77.31 | Jan 19, 2018 | M | 18,672 | D | — | Feb 4, 2024 | Common Stock | 18,672 | 2,578 | D |
| Stock Option (Right to Buy)F8 | $83.36 | Jan 19, 2018 | M | 13,750 | D | — | Jul 29, 2023 | Common Stock | 13,750 | 13,750 | D |
| Stock Option (Right to Buy)F8 | $83.36 | Jan 22, 2018 | M | 13,750 | D | — | Jul 29, 2023 | Common Stock | 13,750 | 0 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $157.67 (range $157.18 to $158.17).
- F3Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $158.59 (range $158.20 to $159.10).
- F5Open market sales reported on this line occurred at a weighted average price of $159.35 (range $159.27 to $159.45).
- F6Reflects a change in the form of ownership resulting from transfers of shares between a trust and Mr. Sachdev.
- F7The option vests in 16 quarterly installments from 2/5/2014.
- F8Fully vested.